Us Monkeypox Testing Market Size By Applications, By Type, By End-User, By Deployment & By Technology 2032
Monkeypox Testing Market was valued at USD 0.8 Billion in 2022 and is projected to reach USD 1.5 Billion by 2030, growing at a CAGR of 8.6% from 2024 to 2030.
The U.S. monkeypox testing market has experienced significant fluctuations in recent years. In 2022, the market was valued at approximately USD 5.34 million, but projections indicate a sharp decline to about USD 91,000 by 2025, reflecting a compound annual growth rate (CAGR) of -74.26%. This downturn is primarily attributed to the effective containment of the 2022 outbreak and the subsequent decrease in testing demand.
During the 2022 outbreak, the United States reported over 28,000 monkeypox cases, with men comprising the majority of patients. The rapid spread prompted health authorities to enhance testing capacities and expedite regulatory approvals for diagnostic tools. The Centers for Disease Control and Prevention (CDC) expanded testing to 78 sites across 48 states, enabling approximately 10,000 tests per week. Additionally, collaborations with commercial laboratories further bolstered testing accessibility.
Diagnostic companies responded swiftly to the outbreak. Labcorp, for instance, processed around 500 monkeypox tests monthly during the peak of the outbreak but had the capacity to scale up to 25,000 tests if necessary. Similarly, other companies like Roche worked to enhance global testing capabilities, collaborating with regulators to integrate monkeypox testing into existing healthcare infrastructures.
Despite the current decline in testing demand, the market remains vigilant due to the potential emergence of new strains. In August 2024, a new form of the virus, clade Ib, was detected outside Africa for the first time, leading to confirmed cases in Sweden and Thailand. In response, U.S. health officials have intensified testing and vaccination efforts to prepare for possible domestic cases. The CDC has authorized any American doctor to order a monkeypox test, and positive results are sent for further confirmation. Vaccines, including Bavarian Nordic's Jynneos, are now widely available through pharmacies, public health departments, and community health centers, ensuring readiness against potential outbreaks.
In my experience, the rapid mobilization of resources during the 2022 outbreak underscored the importance of a robust public health infrastructure. The collaboration between government agencies, commercial laboratories, and healthcare providers was instrumental in controlling the spread. As we navigate potential future threats, maintaining this collaborative approach and ensuring the availability of diagnostic tools will be crucial in safeguarding public health.
Get an In-Depth Research Analysis of the Global Monkeypox Testing Market Size And Forecast [2025-2032]
Aegis Sciences Corp.
Laboratory Corp. of America Holdings
Quest Diagnostics
Inc.
Sonic Healthcare Ltd.
QIAGEN
Mayo Clinic Laboratories
Chembio Diagnostics
Inc.
Sonora Quest Laboratories
Thermo Fisher Scientific
BD
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Monkeypox Testing Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Monkeypox Testing Market
Polymerase Chain Reaction (PCR) Tests
Serologic Tests
Antigen Detection Tests
Culture Tests
Clinical Diagnostics
Research Laboratories
Public Health Surveillance
Veterinary Applications
Hospitals
Diagnostic Laboratories
Academic and Research Institutions
Public Health Organizations
Pharmaceutical Companies
Blood Samples
Skin Lesion Samples
Swabs from Affected Areas
Other Biological Fluids
Direct Sales
Online Sales
Third-party Distributors
Healthcare Institutions
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Monkeypox Testing Market Research Analysis
1. Introduction of the Global Monkeypox Testing Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Monkeypox Testing Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Monkeypox Testing Market, By Type
6. Global Monkeypox Testing Market, By Application
7. Global Monkeypox Testing Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Monkeypox Testing Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/